{
  "ticker": "BMY",
  "year": 2024,
  "quarter": 1,
  "last_updated": "2025-04-19T08:13:02.121868",
  "count": 73,
  "transactions": [
    {
      "id": 14770,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "LEUNG SANDRA",
      "reporting_owner_cik": "0001199294",
      "reporting_owner_position": "EVP, General Counsel",
      "transaction_date": "2024-03-10",
      "transaction_shares": "5789",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "337203.333"
    },
    {
      "id": 14772,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Elkins David V",
      "reporting_owner_cik": "0001451604",
      "reporting_owner_position": "EVP, Chief Financial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "8027",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "176639"
    },
    {
      "id": 14775,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Gallman Cari",
      "reporting_owner_cik": "0001995058",
      "reporting_owner_position": "EVP, Corporate Affairs",
      "transaction_date": "2024-03-10",
      "transaction_shares": "318",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "524"
    },
    {
      "id": 14776,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Plenge Robert M",
      "reporting_owner_cik": "0001773367",
      "reporting_owner_position": "EVP, Chief Research Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "994",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "7920"
    },
    {
      "id": 14778,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Lenkowsky Adam",
      "reporting_owner_cik": "0001975719",
      "reporting_owner_position": "EVP, Chief Commercial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "1698",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "2224"
    },
    {
      "id": 14780,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Poole Ahn Amanda",
      "reporting_owner_cik": "0002005210",
      "reporting_owner_position": "EVP, Chief Human Resources",
      "transaction_date": "2024-03-10",
      "transaction_shares": "628",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "628"
    },
    {
      "id": 14781,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Hirawat Samit",
      "reporting_owner_cik": "0001781290",
      "reporting_owner_position": "EVP,Chief Med.Offr.,Drug Dev.",
      "transaction_date": "2024-03-10",
      "transaction_shares": "4192",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "51437"
    },
    {
      "id": 14782,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Holzer Phil M",
      "reporting_owner_cik": "0002012588",
      "reporting_owner_position": "SVP and Controller",
      "transaction_date": "2024-03-10",
      "transaction_shares": "613",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "10624"
    },
    {
      "id": 14783,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "BOERNER CHRISTOPHER S.",
      "reporting_owner_cik": "0001543747",
      "reporting_owner_position": "Chief Executive Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "5743",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "88415"
    },
    {
      "id": 14784,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Caforio Giovanni",
      "reporting_owner_cik": "0001533201",
      "reporting_owner_position": "Executive Chair of the Board",
      "transaction_date": "2024-03-10",
      "transaction_shares": "23409",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "390904.333"
    },
    {
      "id": 14788,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Hoch Lynelle",
      "reporting_owner_cik": "0002005382",
      "reporting_owner_position": "President, Cell Therapy Org.",
      "transaction_date": "2024-03-10",
      "transaction_shares": "539",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "539"
    },
    {
      "id": 27781,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "LEUNG SANDRA",
      "reporting_owner_cik": "0001199294",
      "reporting_owner_position": "EVP, General Counsel",
      "transaction_date": "2024-03-10",
      "transaction_shares": "5789",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "337203.333"
    },
    {
      "id": 27784,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Elkins David V",
      "reporting_owner_cik": "0001451604",
      "reporting_owner_position": "EVP, Chief Financial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "8027",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "176639"
    },
    {
      "id": 27788,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Gallman Cari",
      "reporting_owner_cik": "0001995058",
      "reporting_owner_position": "EVP, Corporate Affairs",
      "transaction_date": "2024-03-10",
      "transaction_shares": "318",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "524"
    },
    {
      "id": 27789,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Plenge Robert M",
      "reporting_owner_cik": "0001773367",
      "reporting_owner_position": "EVP, Chief Research Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "994",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "7920"
    },
    {
      "id": 27792,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Lenkowsky Adam",
      "reporting_owner_cik": "0001975719",
      "reporting_owner_position": "EVP, Chief Commercial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "1698",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "2224"
    },
    {
      "id": 27795,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Poole Ahn Amanda",
      "reporting_owner_cik": "0002005210",
      "reporting_owner_position": "EVP, Chief Human Resources",
      "transaction_date": "2024-03-10",
      "transaction_shares": "628",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "628"
    },
    {
      "id": 27796,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Hirawat Samit",
      "reporting_owner_cik": "0001781290",
      "reporting_owner_position": "EVP,Chief Med.Offr.,Drug Dev.",
      "transaction_date": "2024-03-10",
      "transaction_shares": "4192",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "51437"
    },
    {
      "id": 27797,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Holzer Phil M",
      "reporting_owner_cik": "0002012588",
      "reporting_owner_position": "SVP and Controller",
      "transaction_date": "2024-03-10",
      "transaction_shares": "613",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "10624"
    },
    {
      "id": 27798,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "BOERNER CHRISTOPHER S.",
      "reporting_owner_cik": "0001543747",
      "reporting_owner_position": "Chief Executive Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "5743",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "88415"
    },
    {
      "id": 27799,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Caforio Giovanni",
      "reporting_owner_cik": "0001533201",
      "reporting_owner_position": "Executive Chair of the Board",
      "transaction_date": "2024-03-10",
      "transaction_shares": "23409",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "390904.333"
    },
    {
      "id": 27804,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Hoch Lynelle",
      "reporting_owner_cik": "0002005382",
      "reporting_owner_position": "President, Cell Therapy Org.",
      "transaction_date": "2024-03-10",
      "transaction_shares": "539",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "539"
    },
    {
      "id": 44824,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "LEUNG SANDRA",
      "reporting_owner_cik": "0001199294",
      "reporting_owner_position": "EVP, General Counsel",
      "transaction_date": "2024-03-10",
      "transaction_shares": "5789",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "337203.333"
    },
    {
      "id": 44827,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Elkins David V",
      "reporting_owner_cik": "0001451604",
      "reporting_owner_position": "EVP, Chief Financial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "8027",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "176639"
    },
    {
      "id": 44831,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Gallman Cari",
      "reporting_owner_cik": "0001995058",
      "reporting_owner_position": "EVP, Corporate Affairs",
      "transaction_date": "2024-03-10",
      "transaction_shares": "318",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "524"
    },
    {
      "id": 44832,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Plenge Robert M",
      "reporting_owner_cik": "0001773367",
      "reporting_owner_position": "EVP, Chief Research Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "994",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "7920"
    },
    {
      "id": 44835,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Lenkowsky Adam",
      "reporting_owner_cik": "0001975719",
      "reporting_owner_position": "EVP, Chief Commercial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "1698",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "2224"
    },
    {
      "id": 44839,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Poole Ahn Amanda",
      "reporting_owner_cik": "0002005210",
      "reporting_owner_position": "EVP, Chief Human Resources",
      "transaction_date": "2024-03-10",
      "transaction_shares": "628",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "628"
    },
    {
      "id": 44840,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Hirawat Samit",
      "reporting_owner_cik": "0001781290",
      "reporting_owner_position": "EVP,Chief Med.Offr.,Drug Dev.",
      "transaction_date": "2024-03-10",
      "transaction_shares": "4192",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "51437"
    },
    {
      "id": 44841,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Holzer Phil M",
      "reporting_owner_cik": "0002012588",
      "reporting_owner_position": "SVP and Controller",
      "transaction_date": "2024-03-10",
      "transaction_shares": "613",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "10624"
    },
    {
      "id": 44842,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "BOERNER CHRISTOPHER S.",
      "reporting_owner_cik": "0001543747",
      "reporting_owner_position": "Chief Executive Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "5743",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "88415"
    },
    {
      "id": 44843,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Caforio Giovanni",
      "reporting_owner_cik": "0001533201",
      "reporting_owner_position": "Executive Chair of the Board",
      "transaction_date": "2024-03-10",
      "transaction_shares": "23409",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "390904.333"
    },
    {
      "id": 44848,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Hoch Lynelle",
      "reporting_owner_cik": "0002005382",
      "reporting_owner_position": "President, Cell Therapy Org.",
      "transaction_date": "2024-03-10",
      "transaction_shares": "539",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "539"
    },
    {
      "id": 64585,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "LEUNG SANDRA",
      "reporting_owner_cik": "0001199294",
      "reporting_owner_position": "EVP, General Counsel",
      "transaction_date": "2024-03-10",
      "transaction_shares": "5789",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "337203.333"
    },
    {
      "id": 64588,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Elkins David V",
      "reporting_owner_cik": "0001451604",
      "reporting_owner_position": "EVP, Chief Financial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "8027",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "176639"
    },
    {
      "id": 64592,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Gallman Cari",
      "reporting_owner_cik": "0001995058",
      "reporting_owner_position": "EVP, Corporate Affairs",
      "transaction_date": "2024-03-10",
      "transaction_shares": "318",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "524"
    },
    {
      "id": 64593,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Plenge Robert M",
      "reporting_owner_cik": "0001773367",
      "reporting_owner_position": "EVP, Chief Research Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "994",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "7920"
    },
    {
      "id": 64596,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Lenkowsky Adam",
      "reporting_owner_cik": "0001975719",
      "reporting_owner_position": "EVP, Chief Commercial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "1698",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "2224"
    },
    {
      "id": 64600,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Poole Ahn Amanda",
      "reporting_owner_cik": "0002005210",
      "reporting_owner_position": "EVP, Chief Human Resources",
      "transaction_date": "2024-03-10",
      "transaction_shares": "628",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "628"
    },
    {
      "id": 64601,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Hirawat Samit",
      "reporting_owner_cik": "0001781290",
      "reporting_owner_position": "EVP,Chief Med.Offr.,Drug Dev.",
      "transaction_date": "2024-03-10",
      "transaction_shares": "4192",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "51437"
    },
    {
      "id": 64602,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Holzer Phil M",
      "reporting_owner_cik": "0002012588",
      "reporting_owner_position": "SVP and Controller",
      "transaction_date": "2024-03-10",
      "transaction_shares": "613",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "10624"
    },
    {
      "id": 64603,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "BOERNER CHRISTOPHER S.",
      "reporting_owner_cik": "0001543747",
      "reporting_owner_position": "Chief Executive Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "5743",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "88415"
    },
    {
      "id": 64604,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Caforio Giovanni",
      "reporting_owner_cik": "0001533201",
      "reporting_owner_position": "Executive Chair of the Board",
      "transaction_date": "2024-03-10",
      "transaction_shares": "23409",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "390904.333"
    },
    {
      "id": 64609,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Hoch Lynelle",
      "reporting_owner_cik": "0002005382",
      "reporting_owner_position": "President, Cell Therapy Org.",
      "transaction_date": "2024-03-10",
      "transaction_shares": "539",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "539"
    },
    {
      "id": 86556,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "LEUNG SANDRA",
      "reporting_owner_cik": "0001199294",
      "reporting_owner_position": "EVP, General Counsel",
      "transaction_date": "2024-03-10",
      "transaction_shares": "5789",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "337203.333"
    },
    {
      "id": 86559,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Elkins David V",
      "reporting_owner_cik": "0001451604",
      "reporting_owner_position": "EVP, Chief Financial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "8027",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "176639"
    },
    {
      "id": 86565,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Gallman Cari",
      "reporting_owner_cik": "0001995058",
      "reporting_owner_position": "EVP, Corporate Affairs",
      "transaction_date": "2024-03-10",
      "transaction_shares": "318",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "524"
    },
    {
      "id": 86566,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Plenge Robert M",
      "reporting_owner_cik": "0001773367",
      "reporting_owner_position": "EVP, Chief Research Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "994",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "7920"
    },
    {
      "id": 86569,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Lenkowsky Adam",
      "reporting_owner_cik": "0001975719",
      "reporting_owner_position": "EVP, Chief Commercial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "1698",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "2224"
    },
    {
      "id": 86576,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Poole Ahn Amanda",
      "reporting_owner_cik": "0002005210",
      "reporting_owner_position": "EVP, Chief Human Resources",
      "transaction_date": "2024-03-10",
      "transaction_shares": "628",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "628"
    },
    {
      "id": 86577,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Hirawat Samit",
      "reporting_owner_cik": "0001781290",
      "reporting_owner_position": "EVP,Chief Med.Offr.,Drug Dev.",
      "transaction_date": "2024-03-10",
      "transaction_shares": "4192",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "51437"
    },
    {
      "id": 86578,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Holzer Phil M",
      "reporting_owner_cik": "0002012588",
      "reporting_owner_position": "SVP and Controller",
      "transaction_date": "2024-03-10",
      "transaction_shares": "613",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "10624"
    },
    {
      "id": 86579,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "BOERNER CHRISTOPHER S.",
      "reporting_owner_cik": "0001543747",
      "reporting_owner_position": "Chief Executive Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "5743",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "88415"
    },
    {
      "id": 86580,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Caforio Giovanni",
      "reporting_owner_cik": "0001533201",
      "reporting_owner_position": "Executive Chair of the Board",
      "transaction_date": "2024-03-10",
      "transaction_shares": "23409",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "390904.333"
    },
    {
      "id": 86585,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Hoch Lynelle",
      "reporting_owner_cik": "0002005382",
      "reporting_owner_position": "President, Cell Therapy Org.",
      "transaction_date": "2024-03-10",
      "transaction_shares": "539",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "539"
    },
    {
      "id": 110818,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "LEUNG SANDRA",
      "reporting_owner_cik": "0001199294",
      "reporting_owner_position": "EVP, General Counsel",
      "transaction_date": "2024-03-10",
      "transaction_shares": "5789",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "337203.333"
    },
    {
      "id": 110821,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Elkins David V",
      "reporting_owner_cik": "0001451604",
      "reporting_owner_position": "EVP, Chief Financial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "8027",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "176639"
    },
    {
      "id": 110827,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Gallman Cari",
      "reporting_owner_cik": "0001995058",
      "reporting_owner_position": "EVP, Corporate Affairs",
      "transaction_date": "2024-03-10",
      "transaction_shares": "318",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "524"
    },
    {
      "id": 110828,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Plenge Robert M",
      "reporting_owner_cik": "0001773367",
      "reporting_owner_position": "EVP, Chief Research Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "994",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "7920"
    },
    {
      "id": 110831,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Lenkowsky Adam",
      "reporting_owner_cik": "0001975719",
      "reporting_owner_position": "EVP, Chief Commercial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "1698",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "2224"
    },
    {
      "id": 110838,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Poole Ahn Amanda",
      "reporting_owner_cik": "0002005210",
      "reporting_owner_position": "EVP, Chief Human Resources",
      "transaction_date": "2024-03-10",
      "transaction_shares": "628",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "628"
    },
    {
      "id": 110839,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Hirawat Samit",
      "reporting_owner_cik": "0001781290",
      "reporting_owner_position": "EVP,Chief Med.Offr.,Drug Dev.",
      "transaction_date": "2024-03-10",
      "transaction_shares": "4192",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "51437"
    },
    {
      "id": 110840,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Holzer Phil M",
      "reporting_owner_cik": "0002012588",
      "reporting_owner_position": "SVP and Controller",
      "transaction_date": "2024-03-10",
      "transaction_shares": "613",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "10624"
    },
    {
      "id": 110841,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "BOERNER CHRISTOPHER S.",
      "reporting_owner_cik": "0001543747",
      "reporting_owner_position": "Chief Executive Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "5743",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "88415"
    },
    {
      "id": 110842,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Caforio Giovanni",
      "reporting_owner_cik": "0001533201",
      "reporting_owner_position": "Executive Chair of the Board",
      "transaction_date": "2024-03-10",
      "transaction_shares": "23409",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "390904.333"
    },
    {
      "id": 110847,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Hoch Lynelle",
      "reporting_owner_cik": "0002005382",
      "reporting_owner_position": "President, Cell Therapy Org.",
      "transaction_date": "2024-03-10",
      "transaction_shares": "539",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "539"
    },
    {
      "id": 4720,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Meyers Gregory Scott",
      "reporting_owner_cik": "0001908769",
      "reporting_owner_position": "EVP, Chief Digital & Tech Off.",
      "transaction_date": "2024-02-01",
      "transaction_shares": "2543",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "6040"
    },
    {
      "id": 14785,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Meyers Gregory Scott",
      "reporting_owner_cik": "0001908769",
      "reporting_owner_position": "EVP, Chief Digital & Tech Off.",
      "transaction_date": "2024-02-01",
      "transaction_shares": "2543",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "6040"
    },
    {
      "id": 27800,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Meyers Gregory Scott",
      "reporting_owner_cik": "0001908769",
      "reporting_owner_position": "EVP, Chief Digital & Tech Off.",
      "transaction_date": "2024-02-01",
      "transaction_shares": "2543",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "6040"
    },
    {
      "id": 44844,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Meyers Gregory Scott",
      "reporting_owner_cik": "0001908769",
      "reporting_owner_position": "EVP, Chief Digital & Tech Off.",
      "transaction_date": "2024-02-01",
      "transaction_shares": "2543",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "6040"
    },
    {
      "id": 64605,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Meyers Gregory Scott",
      "reporting_owner_cik": "0001908769",
      "reporting_owner_position": "EVP, Chief Digital & Tech Off.",
      "transaction_date": "2024-02-01",
      "transaction_shares": "2543",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "6040"
    },
    {
      "id": 86581,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Meyers Gregory Scott",
      "reporting_owner_cik": "0001908769",
      "reporting_owner_position": "EVP, Chief Digital & Tech Off.",
      "transaction_date": "2024-02-01",
      "transaction_shares": "2543",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "6040"
    },
    {
      "id": 110843,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Meyers Gregory Scott",
      "reporting_owner_cik": "0001908769",
      "reporting_owner_position": "EVP, Chief Digital & Tech Off.",
      "transaction_date": "2024-02-01",
      "transaction_shares": "2543",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "6040"
    }
  ]
}